Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease

Neuroscience Letters

Volumn 248, Issue 3, 1998, Pages 171-174

  Sañudo Peña, M Clara ^a   Patrick, Saundra L ^a   Khen, Somphone ^a   Patrick, Robert L ^a   Tsou, Kang ^a   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

6 Hydroxydopamine; Cannabinoids; Circling; Globus pallidus; Striatum; Substantia nigra

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; GLOBUS PALLIDUS; LOCOMOTION; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATION; SUBSTANTIA NIGRA;

ANIMALS; BASAL GANGLIA; CANNABINOIDS; CORPUS STRIATUM; CYCLOHEXANOLS; GLOBUS PALLIDUS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0032486361     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00368-1     Document Type: Article

References (35)

1. Ahamed M., Weiner N. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. J. Pharmacol. Exp. Ther. 275:1995;237-244.
2. Aiko Y., Hosokawa S., Shima F., Kato M., Kitamura K. Alterations in local cerebral glucose utilization during electrical stimulation of the striatum and globus pallidus in rats. Brain Res. 442:1988;43-52.
3. Breese G.R., Traylor T.D. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 174:1970;413-420.
4. Costall B., Kelly D.M., Naylor R.J. Nomifensine: a potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia. 41:1975;153-164.
5. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., Childers S.R. Cannabinoids modulate potassium current in culture hippocampal neurons. Receptors Channels. 1:1993;121-134.
6. Deniau J.M., Hammond C., Chevalier G., Feger J. Evidence for branched subthalamic nucleus projections to substantia nigra, entopeduncular nucleus and globus pallidus. Neurosci. Lett. 9:1978;117-121.
7. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-253.
8. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of a cannabinoid receptor in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
9. Herkenham M., Lynn A.B., de Costa B.R., Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547:1991;267-274.
10. Herrera-Marschitz M., Ungerstedt U. The dopamine-γ aminobutyric acid interaction in the striatum of the rat is dfferently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. Acta Physiol. Scand. 129:1987;371-380.
11. Kawaguchi Y., Wilson C.J., Emson P.C.J. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. Neuroscience. 10:1990;3421-3438.
12. Kita H., Kitai S.T.J. Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. Comp. Neurol. 260:1987;435-452.
13. Mackie K., Hille B. Cannabinoid inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. 89:1992;3825-3829.
14. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Neuroscience. 15:1995;6552-6561.
15. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 48:1992;655-688.
16. Miller A., Walker J.M. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmacol. 279:1995;179-185.
17. Miller A., Walker J.M. Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus. Eur. J. Pharmacol. 304:1996;29-35.
18. Olpe H.R., Schellenberg H., Koella W.P. Rotational behavior induced in rats by intranigral application of GABA-related drugs and GABA antagonist. Eur. J. Pharmacol. 45:1977;291-294.
19. Patrick S.L., Walker J.M., Perkel J.M., Lockwood M., Patrick R.L. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands. Brain Res. 231:1993;243-249.
20. Robledo P., Feger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518:1990;47-54.
21. Robledo P., Feger J.J. Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complex. Neural. Transm. 86:1991;115-126.
22. Rosales M.G., Flores G., Hernandez S., Martinez-Fong D., Aceves J. Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res. 645:1994;335-337.
23. Sañudo-Peña M.C., Patrick S.L., Patrick R.L., Walker J.M. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Neurosci. Lett. 206:1996;21-24.
24. Sañudo-Peña M.C., Walker J.M. Role of the subthalamic nucleus on cannabinoid actions in the substantia nigra of the rat. J. Neurophysiol. 77:1997;1635-1638.
25. Sañudo-Peña M.C., Walker J.M. Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse. 28:1998;27-32.
26. Sañudo-Peña, M.C., Force, M., Tsou, K., Miller, A.S. and Walker, J.M., Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system, Synapse, (1998) in press.
27. Slater P., Lee L.A., Longman D.A., Crossman A.R. An in vivo method for testing putative GABA-like compounds. J. Pharmacol. Methods. 3:1980;39-49.
28. Smith I.D., Grace A.A. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse. 12:1992;287-303.
29. Souilhac J., Poncelet M., Rinaldi-Carmona M., Le-Fur G., Soubrie P. Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol. Biochem. Behav. 51:1995;3-7.
30. Tsou K., Brown S., Sañudo-Peña M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 83:1998;393-411.
31. Wichmann T., Bergman H., DeLong M.R. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of Parkinsonism. J. Neurophysiol. 72:1994;521-530.
32. Wilson C.J. The generation of natural firing patterns in neostriatal neurons. In G.W. Arbuthnott and P.C. Empson (Eds.), Chemical Signalling in the Basal Ganglia. Prog. Brain Res. 99:1993;277-298.
33. Worms P., Gueudet C., Biziere K. Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model. Life Sci. 39:1986;2199-2208.
34. Yamaguchi K., Nabeshima T., Kameyama T. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior. J. Pharmacobiodyn. 9:1986;975-998.
35. 2 receptor agonists. Neuroscience. 63:1994;427-434.